Biological Products, (No Diagnostic Substances) Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Biological Products, (No Diagnostic Substances)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2025-09-10
TILInstil Bio, Inc.Laumas SandeepCFO, CBOS - Sale+OE$23.39-30,0000-100%-$701,667
2025-09-10
RGNXRegenxbio Inc.Simpson CurranCEOS - Sale$10.02-7,734244,597-3%-$77,495
D
2025-09-10
RXRXRecursion Pharmaceuticals, Inc.Gibson ChristopherCEOS - Sale+OE$4.71-100,000954,229-9%-$471,000
D
2025-09-10
TSHATaysha Gene Therapies, Inc.Nagendran SukumarPres, Head of R, DS - Sale+OE$3.23-200,0001,006,439-17%-$646,000
DM
2025-09-10
IMCRImmunocore Holdings PlcBerman David MHEAD OF R, DS - Sale+OE$36.20-50,4190-100%-$1,824,967
D
2025-09-10
HALOHalozyme Therapeutics, Inc.Labrosse NicoleSVP, CFOS - Sale+OE$75.71-20,00024,306-45%-$1,514,267
D
2025-09-10
RGENRepligen CorpHunt AnthonyDirS - Sale+OE$120.52-29,111100,743-22%-$3,508,389
M
2025-09-08
VORVor Biopharma Inc.Reprogrammed Interchange LLC10%S - Sale$1.95-1,263,64734,213,292-4%-$2,457,975
2025-09-08
IPSCCentury Therapeutics, Inc.Carr DouglasSVP Finance, OperationsS - Sale$0.50-263405,4230%-$132
2025-09-08
IPSCCentury Therapeutics, Inc.Pfeiffenberger BrentPres, CEOS - Sale$0.50-4883,268,9090%-$244
2025-09-08
IPSCCentury Therapeutics, Inc.Russotti GregorySee RemarksS - Sale$0.50-539484,2810%-$270
2025-09-08
TARSTarsus Pharmaceuticals, Inc.Link William J PhdDirS - Sale$57.00-27,116153,778-15%-$1,545,612
A
2025-08-18
LXEOLexeo Therapeutics, Inc.Townsend Richard NolanCEOS - Sale$4.67-1,115220,058-1%-$5,205
M
2025-09-08
DNAGinkgo Bioworks Holdings, Inc.Henry Christian ODirS - Sale$10.99-20,00024,310-45%-$219,800
2025-09-08
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$25.76-269103,0370%-$6,929
2025-09-08
TWSTTwist Bioscience CorpGreen PaulaSVP of HRS - Sale$25.76-892124,837-1%-$22,978
D
2025-09-08
TWSTTwist Bioscience CorpLeproust Emily M.CEOS - Sale+OE$25.76-2,265634,7400%-$58,346
2025-09-08
TWSTTwist Bioscience CorpWerner Robert F.Chief Accounting OfficerS - Sale$25.76-23548,4540%-$6,054
D
2025-09-05
CGONCg Oncology, Inc.Mulay JamesDirS - Sale+OE$31.53-27,0150-100%-$851,797
2025-09-03
APGEApogee Therapeutics, Inc.Dambkowski CarlChief Medical OfficerS - Sale$37.87-2,725233,548-1%-$103,198
M
2025-09-03
VORVor Biopharma Inc.Reprogrammed Interchange LLC10%S - Sale$1.97-1,407,62835,476,939-4%-$2,767,982
DM
2025-09-02
RVMDRevolution Medicines, Inc.Anders JackCFOS - Sale+OE$40.10-10,000113,314-8%-$400,992
DM
2025-09-02
HALOHalozyme Therapeutics, Inc.Torley HelenPres, CEOS - Sale+OE$74.08-60,000733,719-8%-$4,444,626
2025-09-03
CGONCg Oncology, Inc.Song Hong FangDirS - Sale$27.80-100,0007,039,077-1%-$2,779,542
2025-09-02
ALECAlector, Inc.Wong-Sarad GracePrincipal Accounting OfficerS - Sale$2.50-5,910103,448-5%-$14,756
2025-09-02
ALECAlector, Inc.Berkley Neil LindsayPrincipal Financial OfficerS - Sale$2.50-15,842346,570-4%-$39,554
D
2025-09-03
CGONCg Oncology, Inc.Post Leonard EDirS - Sale+OE$28.00-1,0000-100%-$28,000
2025-09-02
ALECAlector, Inc.Kenkare-Mitra SaraPres, Head of R, DS - Sale$2.50-23,638543,339-4%-$59,019
2025-09-02
ALECAlector, Inc.Rosenthal ArnonCEOS - Sale$2.50-51,5626,280,595-1%-$128,740
2025-09-03
EDITEditas Medicine, Inc.Burkly LindaEVP, CHIEF SCIENTIFIC OFFICERS - Sale$2.60-71069,490-1%-$1,843
2025-09-03
EDITEditas Medicine, Inc.Parison AmySVP, CFOS - Sale$2.60-45816,369-3%-$1,189
2025-09-03
EDITEditas Medicine, Inc.O'Neill Gilmore NeilCEOS - Sale$2.60-5,592274,690-2%-$14,517
2025-09-04
FENCFennec Pharmaceuticals Inc.Raykov RostyDirS - Sale$8.92-10,00051,086-16%-$89,200
2025-09-02
ADAPAdaptimmune Therapeutics PlcWood GavinCFOS - Sale$0.01-96,0000-100%-$950
D
2025-09-02
VCELVericel CorpHopper Jonathan MarkChief Medical OfficerS - Sale+OE$35.77-10,00066,363-13%-$357,700
2025-09-02
VIRVir Biotechnology, Inc.Sato Vicki LDirS - Sale$4.99-22,0001,254,391-2%-$109,811
2025-09-02
HALOHalozyme Therapeutics, Inc.Connaughton BernadetteDirS - Sale$73.68-4,00046,952-8%-$294,736
D
2025-09-02
BIIBBiogen Inc.Singhal PriyaHead of DevelopmentS - Sale+OE$133.55-5175,772-8%-$69,045
2025-08-28
ADAPAdaptimmune Therapeutics PlcBertrand William C JrCOOS - Sale$0.01-207,000986,352-17%-$2,091
M
2025-08-27
VORVor Biopharma Inc.Reprogrammed Interchange LLC10%S - Sale$2.01-1,417,99836,884,567-4%-$2,848,511
2025-08-28
GILDGilead Sciences, Inc.O'Day Daniel PatrickCOB, CEOS - Sale$113.63-10,000595,725-2%-$1,136,300
D
2025-08-26
RXRXRecursion Pharmaceuticals, Inc.Gibson ChristopherCEOS - Sale+OE$4.84-100,000954,229-9%-$484,000
2025-08-26
ALECAlector, Inc.Hammond PaulaDirS - Sale$2.36-14,00074,909-16%-$32,998
M
2025-08-25
VORVor Biopharma Inc.Reprogrammed Interchange LLC10%S - Sale$2.10-671,53638,302,565-2%-$1,411,083
D
2025-08-25
TECHBio-Techne CorpNusse RoelandDirS - Sale+OE$56.36-17,04044,559-28%-$960,388
D
2025-08-25
TECHBio-Techne CorpBaumgartner Robert VDirS - Sale+OE$56.21-17,04044,863-28%-$957,818
2025-08-25
TWSTTwist Bioscience CorpWerner Robert F.Chief Accounting OfficerS - Sale$27.69-85348,689-2%-$23,620
M
2025-08-22
LENZLenz Therapeutics, Inc.Versant Venture Capital Vi, L.P.10%S - Sale$39.47-188,0943,017,166-6%-$7,423,920
D
2025-08-22
DNAGinkgo Bioworks Holdings, Inc.Coen Steven P.See remarksS - Sale+OE$12.40-31011,112-3%-$3,843
D
2025-08-21
CLDICalidi Biotherapeutics, Inc.Schoeneck James ADirP - Purchase$2.00+75,00084,514+788%+$150,000
D
2025-08-21
CLDICalidi Biotherapeutics, Inc.Poma Eric ECEOP - Purchase$2.00+25,00025,000New+$50,000
D
2025-08-21
CLDICalidi Biotherapeutics, Inc.Leftwich ScottDirP - Purchase$2.00+125,000146,631+578%+$250,000
D
2025-08-21
CLDICalidi Biotherapeutics, Inc.Jackson Andrew C.CFOP - Purchase$2.00+2,5002,500New+$5,000
D
2025-08-21
TWSTTwist Bioscience CorpLeproust Emily M.CEOS - Sale+OE$25.96-2,716637,0050%-$70,518
2025-08-21
TWSTTwist Bioscience CorpWerner Robert F.Chief Accounting OfficerS - Sale$25.96-23849,5420%-$6,179
2025-08-21
TWSTTwist Bioscience CorpGreen PaulaSVP of HRS - Sale$25.96-619125,7290%-$16,072
2025-08-21
TWSTTwist Bioscience CorpLaponis AdamCFOS - Sale$25.96-918102,917-1%-$23,835
2025-08-21
TWSTTwist Bioscience CorpFinn Patrick JohnPres, COOS - Sale$25.96-1,840233,529-1%-$47,774
2025-08-21
TWSTTwist Bioscience CorpCho DennisSee RemarksS - Sale$25.96-521103,306-1%-$13,527
2025-08-22
BCDABiocardia, Inc.Altman PeterPres, CEOP - Purchase$1.83+700168,7620%+$1,281
2025-08-20
AMGNAmgen IncGrygiel Nancy A.SVP, CCOS - Sale$296.99-1,2677,313-15%-$376,280
2025-08-21
TSHATaysha Gene Therapies, Inc.Nagendran SukumarPres, Head of R, DS - Sale$2.85-57,0541,165,289-5%-$162,604
2025-08-21
TSHATaysha Gene Therapies, Inc.Alam KamranCFOS - Sale$2.85-54,4911,187,603-4%-$155,299
2025-08-18
ACOGAlpha Cognition Inc.Wills Robert JamesDirP - Purchase$8.49+15,00015,000New+$127,328
M
2025-08-18
HUMAHumacyte, Inc.Dougan Brady WDirS - Sale$1.67-2,241,0451,392,091-62%-$3,733,191
M
2025-08-18
HUMAHumacyte, Inc.Niklason Laura EPres, CEO, DirS - Sale$1.67-2,241,0451,392,091-62%-$3,733,191
2025-08-18
LXEOLexeo Therapeutics, Inc.Otero Jose ManuelChief Technical OfficerS - Sale$4.67-2,84860,372-5%-$13,294
2025-08-18
LXEOLexeo Therapeutics, Inc.Robertson JennyGCS - Sale$4.67-54262,556-1%-$2,530
2025-08-18
LXEOLexeo Therapeutics, Inc.Adler EricChief Medical OfficerS - Sale$4.67-60867,073-1%-$2,838
2025-08-18
LXEOLexeo Therapeutics, Inc.Townsend Richard NolanCEOS - Sale$4.67-2,735220,058-1%-$12,767
2025-08-18
LXEOLexeo Therapeutics, Inc.See Tai SandiChief Development OfficerS - Sale$4.67-38258,860-1%-$1,783
2025-08-18
ACOGAlpha Cognition Inc.Mertz Phillip JosephDirS - Sale$9.00-27,77835,022-44%-$250,002
2025-08-18
ATRAAtara Biotherapeutics, Inc.Nguyen AnhcoPres, CEOS - Sale$11.62-2,95867,889-4%-$34,360
2025-08-18
ATRAAtara Biotherapeutics, Inc.Grant-Huerta YaninaChief Accounting OfficerS - Sale$11.61-1,80935,258-5%-$21,009
2025-08-18
ACOGAlpha Cognition Inc.Mertz Leonard PowellDirP - Purchase$9.00+27,778259,998+12%+$250,002
2025-08-18
VYGRVoyager Therapeutics, Inc.Ferguson TobyChief Medical OfficerS - Sale$3.73-19,000138,914-12%-$70,870
DM
2025-08-18
IVVDInvivyd, Inc.Lee Timothy EdwardChief Commercial OfficerS - Sale+OE$0.60-49,65659,344-46%-$29,808
DM
2025-08-18
IVVDInvivyd, Inc.Duke William E.CFOS - Sale+OE$0.60-49,65649,344-50%-$29,808
DM
2025-08-18
IVVDInvivyd, Inc.Green JulieCHROS - Sale+OE$0.60-49,65649,344-50%-$29,808
DM
2025-08-18
IVVDInvivyd, Inc.Andersen JillGC, SecretaryS - Sale+OE$0.60-82,75484,946-49%-$49,677
DM
2025-08-18
IVVDInvivyd, Inc.Allen Robert D. IIIChief Scientific OfficerS - Sale+OE$0.60-45,93253,068-46%-$27,573
2025-08-15
REPLReplimune Group, Inc.Hill Emily LuisaCFOS - Sale$5.37-9,154134,368-6%-$49,157
2025-08-15
ATRAAtara Biotherapeutics, Inc.Panacea Innovation Ltd10%P - Purchase$12.19+55,0001,405,000+4%+$670,423
M
2025-08-15
ADAPAdaptimmune Therapeutics PlcBehbahani AliDirS - Sale$0.01-19,500,0000-100%-$229,172
2025-08-18
RXRXRecursion Pharmaceuticals, Inc.Khan NajatChief R, D Commercial OfficerS - Sale$5.52-36,599668,197-5%-$202,173
M
2025-08-15
LENZLenz Therapeutics, Inc.Versant Venture Capital Vi, L.P.10%S - Sale$39.34-260,7133,205,260-8%-$10,255,244
2025-08-18
SRRKScholar Rock Holding CorpParlavecchio CarynCHROS - Sale$31.17-2,178155,464-1%-$67,880
D
2025-08-18
CRSPCrispr Therapeutics AGKulkarni SamarthCEOS - Sale+OE$58.15-13,081292,626-4%-$760,660
M
2025-07-17
VXRTVaxart, Inc.Finney KevinDirP - Purchase$0.37+166,668204,771+437%+$61,934
2025-08-18
TNYATenaya Therapeutics, Inc.Higa TomohiroSVP, FinanceS - Sale$1.25-2,96295,338-3%-$3,711
2025-08-18
TNYATenaya Therapeutics, Inc.Tingley WhittemoreChief Medical OfficerS - Sale$1.25-5,053172,803-3%-$6,331
2025-08-18
TNYATenaya Therapeutics, Inc.Ali FarazCEOS - Sale$1.25-14,533302,792-5%-$18,210
D
2025-08-15
GILDGilead Sciences, Inc.Mercier JohannaChief Commercial OfficerS - Sale+OE$118.53-28,000114,168-20%-$3,318,927
2025-08-15
ARTVArtiva Biotherapeutics, Inc.Aslan FredPres, CEOS - Sale$2.73-25,500382,221-6%-$69,579
2025-08-15
GILDGilead Sciences, Inc.Dickinson Andrew DCFOS - Sale$118.53-2,500160,110-2%-$296,325
D
2025-08-18
AURAAura Biosciences, Inc.Elazzouzi AmySVP, FinanceS - Sale+OE$6.70-7,72286,558-8%-$51,737
D
2025-08-15
ADMAAdma Biologics, Inc.Grossman Adam SPres, CEOS - Sale+OE$16.88-21,0003,756,233-1%-$354,480
D
2025-08-13
BCRXBiocryst Pharmaceuticals IncHeggie TheresaDirS - Sale+OE$8.51-70,00065,352-52%-$595,868
2025-08-12
DNLIDenali Therapeutics Inc.Schuth Alexander O.COFO, SecretaryS - Sale$13.58-2,937766,0950%-$39,884
M
2025-08-12
DNLIDenali Therapeutics Inc.Ho CaroleChief Medical OfficerS - Sale$13.81-3,743424,804-1%-$51,684

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top